Kaplan Ma

3.3k total citations · 1 hit paper
191 papers, 1.7k citations indexed

About

Kaplan Ma is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Kaplan Ma has authored 191 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 86 papers in Oncology, 85 papers in Pulmonary and Respiratory Medicine and 28 papers in Cancer Research. Recurrent topics in Kaplan Ma's work include Colorectal Cancer Treatments and Studies (19 papers), Occupational and environmental lung diseases (15 papers) and Lung Cancer Treatments and Mutations (15 papers). Kaplan Ma is often cited by papers focused on Colorectal Cancer Treatments and Studies (19 papers), Occupational and environmental lung diseases (15 papers) and Lung Cancer Treatments and Mutations (15 papers). Kaplan Ma collaborates with scholars based in Türkiye, United States and Brazil. Kaplan Ma's co-authors include Abdurrahman Işıkdoğan, Zeynep Oruç, Mehmet Küçüköner, Ali̇ İnal, Zuhat Urakçı, Velı Berk, Mustafa Beneklı, Süleyman Buyukberber, Bernard Heinemann and Uğur Çoşkun and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Annals of Oncology.

In The Last Decade

Kaplan Ma

171 papers receiving 1.6k citations

Hit Papers

First-line nivolumab plus ipilimumab versus chemotherapy ... 2022 2026 2023 2024 2022 50 100 150

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kaplan Ma Türkiye 21 604 602 323 221 193 191 1.7k
Giovanni Rossi Italy 26 790 1.3× 1.0k 1.7× 442 1.4× 329 1.5× 303 1.6× 114 2.3k
Junsheng Peng China 22 526 0.9× 611 1.0× 697 2.2× 523 2.4× 225 1.2× 120 1.9k
Junshik Hong South Korea 25 685 1.1× 498 0.8× 325 1.0× 182 0.8× 130 0.7× 179 2.0k
Jianan Huang China 18 450 0.7× 526 0.9× 312 1.0× 143 0.6× 114 0.6× 90 1.4k
Qibin Song China 19 423 0.7× 347 0.6× 674 2.1× 151 0.7× 306 1.6× 88 1.6k
John Sukumar Aluru United States 9 604 1.0× 460 0.8× 615 1.9× 540 2.4× 230 1.2× 12 1.9k
Andrea Gini Netherlands 15 928 1.5× 519 0.9× 472 1.5× 393 1.8× 267 1.4× 27 1.9k
Petra Schrotz‐King Germany 21 670 1.1× 255 0.4× 391 1.2× 222 1.0× 272 1.4× 67 1.3k
Clemens Schafmayer Germany 23 605 1.0× 405 0.7× 412 1.3× 527 2.4× 213 1.1× 61 1.8k

Countries citing papers authored by Kaplan Ma

Since Specialization
Citations

This map shows the geographic impact of Kaplan Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kaplan Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kaplan Ma more than expected).

Fields of papers citing papers by Kaplan Ma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kaplan Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kaplan Ma. The network helps show where Kaplan Ma may publish in the future.

Co-authorship network of co-authors of Kaplan Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Kaplan Ma. A scholar is included among the top collaborators of Kaplan Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kaplan Ma. Kaplan Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bılıcı, Ahmet, Özcan Yıldız, Saadettin Kılıçkap, et al.. (2025). Efficacy of Immunotherapy Versus Chemotherapy in Advanced Pleural Mesothelioma: A Turkish Oncology Group (TOG) Study. Medicina. 61(4). 638–638. 1 indexed citations
2.
Urakçı, Zuhat, Zeynep Oruç, Halil Kömek, et al.. (2025). Comparison of inflammatory indices in patients with metastatic non-small cell lung cancer. Revista da Associação Médica Brasileira. 71(4). e20240411–e20240411.
3.
Urakçı, Zuhat, Kaplan Ma, Zeynep Oruç, et al.. (2024). Superiority of Pathologic Lymph Node Ratio over Positive Lymph Node Count in Operated Early-Stage Breast Cancer. Annali Italiani di Chirurgia. 95(6). 1170–1177. 1 indexed citations
4.
Urakçı, Zuhat, et al.. (2024). Causes of liver test abnormalities in newly diagnosed cancer patients and the investigation of etiological factors. Postgraduate Medicine. 136(2). 162–168. 2 indexed citations
5.
Oruç, Zeynep, et al.. (2023). Factors influencing the prognosis in Braf wild-type metastatic malignant melanoma and the role of novel inflammation indices. SHILAP Revista de lepidopterología. 57(3). 77–82.
6.
Ma, Kaplan, Mevlüde İnanç, Doğan Uncu, et al.. (2022). The Efficacy and Safety of Treatment Regimens Used in the First-Line Setting in Metastatic Pancreatic Cancer Patients. Pancreas. 51(9). 1153–1159. 1 indexed citations
7.
Paydaş, Semra, Şahin Laçin, Mutlu Doğan, et al.. (2021). Easier and more explanatory indices by integrating leukocyte lymphocyte ratio (LLR) and prognostic nutritional index (PNI) to IPS systems in cases with classical Hodgkin lymphoma. Leukemia Research. 107. 106586–106586. 9 indexed citations
8.
Ma, Kaplan, Zeynep Oruç, Mahmut Gümüş, et al.. (2020). The efficacy and reliability of sequential adjuvant anthracycline-based chemotherapy and weekly paclitaxel regimen in human epidermal growth factor receptor 2 negative breast cancer: A retrospective analysis of a multicentre study.. PubMed. 24(3). 1081–1086. 1 indexed citations
9.
Oruç, Zeynep, Kaplan Ma, Çağlayan Geredeli, et al.. (2020). Is eribulin treatment prognostic factor in patients with metastatic breast cancer treated with this drug? Retrospective analysis of a multicentre study.. PubMed. 24(2). 1876–1883. 2 indexed citations
10.
Küçüköner, Mehmet, Sevgi İrtegün Kandemir, Zuhat Urakçı, et al.. (2019). Meme Kanserinde Brca-1 ve Brca-2’de Sık Görülen Polimorfizm Mutasyonların Bölgemizde Varlığı. SHILAP Revista de lepidopterología. 46(4). 623–631. 2 indexed citations
11.
Ma, Kaplan, et al.. (2019). Colorectal cancer in patients aged ≤30 years: 17 years of experience.. 41(1). 62–68. 2 indexed citations
12.
Budakoğlu, Burçin, Kadri Altundağ, Sercan Aksoy, et al.. (2018). Outcome of 561 non-metastatic triple negative breast cancer patients: multi-center experience from Turkey.. PubMed. 19(4). 872–8. 3 indexed citations
13.
Urakçı, Zuhat, et al.. (2018). Mixed Ger m Cell Testis Tumor Presenting w ith Massive Lung Metastasis. DergiPark (Istanbul University). 10(1). 21–26.
14.
Göya, Cemil, et al.. (2018). The importance of acoustic radiation force impulse (ARFI) elastography in the diagnosis and clinical course of acute pancreatitis. The Turkish Journal of Gastroenterology. 29(3). 342–347. 9 indexed citations
15.
Ma, Kaplan, Uğur Fırat, Mehmet Küçüköner, et al.. (2014). Brain metastases in HER2-positive metastatic breast cancer patients who received chemotherapy with or without trastuzumab. Breast Cancer. 22(5). 503–509. 15 indexed citations
16.
Kefeli, Umut, Murat Akyol, Ramazan Yıldız, et al.. (2013). Efficacy of sunitinib in Turkish patients with gastrointestinal stromal tumors; retrospective multicenter experience.. PubMed. 60(124). 647–52. 4 indexed citations
18.
Ma, Kaplan, et al.. (2009). Germ cell tumor in duodenum. The Turkish Journal of Gastroenterology. 24(1). 73–74. 1 indexed citations
19.
Ma, Kaplan, et al.. (1976). Pharmaceutical properties and stability of amikacin - part I.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 20(4). 352–8. 1 indexed citations
20.
Ma, Kaplan, et al.. (1958). An antifungal antibiotic (AYF) produced by a strain of Streptomyces aureofaciens.. PubMed. 8(10). 491–5. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026